Type 1 Diabetes4301NCT00491465
The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.
A study testing Intensive Physical activity in people with Type 1 Diabetes, run by Rabin Medical Center at 1 site in Israel.
Trial summary
Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. Read more about this study
- Who is it for?
- Ages 8 to 16 years
- Conditions the study is for
- Type 1 Diabetes
- What is being tested?
- Intensive Physical activity
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 2,007 participants
- Where
- 1 siteIsrael
- Study dates
- Jul 2007to Jul 2009
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 16 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Type I diabetic children
- Tanner stage II-IV
- Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
- more than one year.
- HbA1C between 8 and 12 at time 0.
- Mandatory 4 daily self blood glucose measurements and daily recording of adverse events.
- A signed informed consent of the parents and child.
Who cannot join
- Additional chronic significant disease such as cardiac, liver, renal disease .
- Children who exercise regularly more than 180 min per week.
- Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
- Eating disorders.
- Participation in a study during the past month.
Trial locations and contacts
1 site in 1 country.
Israel1 site
Schnider children's medical center
Petah Tikva
Ravital Nimri, MD
Moshe Phillip, Prof.
About this study
Official title: Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.
Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.
Read the detailed description
Randomized, controlled, open, comparative, cross-over, intervention study in 50 children with type 1 diabetes.
objectives:
Primary objective To evaluate the efficacy and safety of physical activity for metabolic control in children with type I diabetes.
Secondary objectives
- To characterize the severity and pattern of occurrence of hypo and hyperglycemic episodes during and after exercise program in type I diabetic children.
- To evaluate changes in insulin sensitivity during and after periods of exercise in type I diabetic children.
- To evaluate the short term effect of exercise on BMI and body composition in type I diabetic children.
- To evaluate the short term effect of exercise on lipid profile in type I diabetic children.
- To evaluate differences in self esteem and quality of life between exercising and non exercising type I diabetic children.
Randomization:
Children will be randomly allocated into two groups of 25.The study will be conducted in a crossover manner:one group starting with the intensive arm followed by the non intensive arm and vice versa.
methods:
- The study will have an intensive arm and a non intensive arm, each lasting 12 weeks.
- Children fulfilling the inclusion and exclusion criteria will be randomly assigned to two groups. Each group will include 25 patients.
- Participants will fill questionnaires regarding physical activity.
- The first group will start with the intensive arm, followed by one month washout, and then the non intensive arm.
- The second group will start the study with the non intensive arm, followed by one month washout and then the intensive arm .
- The intensive arm will consist of an exercise program which will include high intensity progressive exercise (75% maximum age adjusted heart rate HRmax) 3 days a week for 90 minutes. The 90 min exercise will be a combination of aerobic exercise 45min. and resistance exercise 45 min.
- The exercise program will be planned and carried out by professional sports instructors.
- During the non intensive arm the participants will resume regular daily activity. They will keep records of their weekly physical activity and will get a weekly phone call from the treating doctor, addressing specifically physical activity performed during the past week and glucose levels before and after exercise.
- The following parameters will be measured for both groups at the beginning and the end of the intensive and non intensive arm and once again 12 weeks afterwards : Weight, height, pulse, blood pressure, waist circumference, skin folds, HbA1C , fructosamine ,3 days CGMS +3 day SBGM profile (will be measured to 40% of participants chosen randomly) ,total daily insulin dose ,blood sample for fasting lipid profile ,Body impedance and BMR , self esteem and quality of life questionnaires .
- Study participants will be required to measure blood glucose by glucometer at least 4 times a day and to record hypo and hyperglycemic events and their severity.
15.Both children and investigators will be blinded to CGMS results. 16.During the 3 day CGMS recording, the children's parents will be asked to monitor SBGM once during the night (in the intensive arm, following the exercise day).
- Conditions
- Type 1 Diabetes
- Being tested
- Intensive Physical activity, Control- regular physical activity
- Keywords
- Type 1 Diabetes, physical activity, pediatric, metabolic control
- Medical subject headings
- Diabetes Mellitus, Type 1, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intensive Physical activityBehavioural
Control- regular physical activityBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
HbA1C
Measured: 0,3 monthes
fructosamine
Measured: 0,3 monthes
Secondary outcomes (3)
Body composition & BMR
Measured: 0,3 monthes
Self esteem & QOL questionnaires
Measured: o, 3 monthes
3 days CGMS & SBGM profile
Measured: 0,3 monthes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2007 (estimated)
- Study startJul 2007
- Study completionJul 2009 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Type 1 DiabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 2,007 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rabin Medical Center
- Sponsor type
- University, hospital or other
- Investigators
- Ravital Nimri, MD, Principal investigator, Rabin Medical CenterMoshe Phillip, Prof, Principal investigator, Rabin Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00491465
- Sponsor's protocol ID
- rmc074301ctil
- Acronym
- 4301
- Status last verified
- Jun 2007
- First submitted
- 25 Jun 2007
- Last updated
- 26 Jun 2007
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.
- ClinicalTrials.gov ID
- NCT00491465
- Acronym / sponsor ID
- 4301 / rmc074301ctil
- Conditions
- Type 1 Diabetes
- Keywords
- Type 1 Diabetes, physical activity, pediatric, metabolic control
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 2,007 participants (estimated)
- Lead sponsor
- Rabin Medical CenterUniversity, hospital or other
- Study start
- Jul 2007
- Study completion
- Jul 2009 (estimated)
- First posted
- 26 Jun 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.
Detailed description
Randomized, controlled, open, comparative, cross-over, intervention study in 50 children with type 1 diabetes.
objectives:
Primary objective To evaluate the efficacy and safety of physical activity for metabolic control in children with type I diabetes.
Secondary objectives
- To characterize the severity and pattern of occurrence of hypo and hyperglycemic episodes during and after exercise program in type I diabetic children.
- To evaluate changes in insulin sensitivity during and after periods of exercise in type I diabetic children.
- To evaluate the short term effect of exercise on BMI and body composition in type I diabetic children.
- To evaluate the short term effect of exercise on lipid profile in type I diabetic children.
- To evaluate differences in self esteem and quality of life between exercising and non exercising type I diabetic children.
Randomization:
Children will be randomly allocated into two groups of 25.The study will be conducted in a crossover manner:one group starting with the intensive arm followed by the non intensive arm and vice versa.
methods:
- The study will have an intensive arm and a non intensive arm, each lasting 12 weeks.
- Children fulfilling the inclusion and exclusion criteria will be randomly assigned to two groups. Each group will include 25 patients.
- Participants will fill questionnaires regarding physical activity.
- The first group will start with the intensive arm, followed by one month washout, and then the non intensive arm.
- The second group will start the study with the non intensive arm, followed by one month washout and then the intensive arm .
- The intensive arm will consist of an exercise program which will include high intensity progressive exercise (75% maximum age adjusted heart rate HRmax) 3 days a week for 90 minutes. The 90 min exercise will be a combination of aerobic exercise 45min. and resistance exercise 45 min.
- The exercise program will be planned and carried out by professional sports instructors.
- During the non intensive arm the participants will resume regular daily activity. They will keep records of their weekly physical activity and will get a weekly phone call from the treating doctor, addressing specifically physical activity performed during the past week and glucose levels before and after exercise.
- The following parameters will be measured for both groups at the beginning and the end of the intensive and non intensive arm and once again 12 weeks afterwards : Weight, height, pulse, blood pressure, waist circumference, skin folds, HbA1C , fructosamine ,3 days CGMS +3 day SBGM profile (will be measured to 40% of participants chosen randomly) ,total daily insulin dose ,blood sample for fasting lipid profile ,Body impedance and BMR , self esteem and quality of life questionnaires .
- Study participants will be required to measure blood glucose by glucometer at least 4 times a day and to record hypo and hyperglycemic events and their severity.
15.Both children and investigators will be blinded to CGMS results. 16.During the 3 day CGMS recording, the children's parents will be asked to monitor SBGM once during the night (in the intensive arm, following the exercise day).
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
Who may qualify
- Ages
- 8 to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Type I diabetic children
- Tanner stage II-IV
- Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
- more than one year.
- HbA1C between 8 and 12 at time 0.
Key exclusion criteria (5 listed)
- Additional chronic significant disease such as cardiac, liver, renal disease .
- Children who exercise regularly more than 180 min per week.
- Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
- Eating disorders.
- Participation in a study during the past month.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intensive Physical activity | Behavioural | – |
| Control- regular physical activity | Behavioural | – |
Primary outcome
HbA1C
Time frame: 0,3 monthes
fructosamine
Time frame: 0,3 monthes
3 secondary outcomes
Body composition & BMR
Time frame: 0,3 monthes
Self esteem & QOL questionnaires
Time frame: o, 3 monthes
3 days CGMS & SBGM profile
Time frame: 0,3 monthes
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2007.
Related trials for Type 1 Diabetes
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
RecruitingPhase 1
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Melanoma
Active, not recruitingPhase 2
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Metastatic Colorectal Cancer
Not yet recruiting
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Continuous Glucose Monitoring, Type 1 Diabetes
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ravital Nimri, MD principal investigator
Rabin Medical Center
Moshe Phillip, Prof principal investigator
Rabin Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intensive Physical activity in people with Type 1 Diabetes, run by Rabin Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Jun 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ravital Nimri, MD (972-39253778 ext. direct, ravitaln@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HbA1C (time frame: 0,3 monthes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2007.